Literature DB >> 6098822

A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation.

T J Liang, G G Carmichael, T L Benjamin.   

Abstract

The hr-t gene of polyoma virus encodes both the small and middle T (tumor) antigens and exerts pleiotropic effects on cells. By mutating the 3' splice site for middle T mRNA, we have constructed a virus mutant, Py808A, which fails to express middle T but encodes normal small and large T proteins. The mutant failed to induce morphological transformation or growth in soft agar, but did stimulate postconfluent growth of normal cells. Cells infected by Py808A became fully agglutinable by lectins while retaining normal actin cable architecture and normal levels of extracellular fibronectin. These properties of Py808A demonstrated the separability of structural changes at the cell surface from those in the cytoskeleton and extracellular matrix, parameters which have heretofore been linked in the action of the hr-t and other viral oncogenes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098822      PMCID: PMC369288          DOI: 10.1128/mcb.4.12.2774-2783.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Purification of polyoma virus.

Authors:  E WINOCOUR
Journal:  Virology       Date:  1963-02       Impact factor: 3.616

2.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Patterns of organization of actin and myosin in normal and transformed cultured cells.

Authors:  R Pollack; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

5.  Construction and expression of a recombinant DNA gene encoding a polyomavirus middle-size tumor antigen with the carboxyl terminus of the vesicular stomatitis virus glycoprotein G.

Authors:  D Templeton; A Voronova; W Eckhart
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

6.  Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.

Authors:  G Carmichael; B S Schaffhausen; G Mandel; T J Liang; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Cell-to-substrate contacts in living fibroblasts: an interference reflexion study with an evaluation of the technique.

Authors:  C S Izzard; L R Lochner
Journal:  J Cell Sci       Date:  1976-06       Impact factor: 5.285

8.  Polyoma middle T antigen requires cooperation from another gene to express the malignant phenotype in vivo.

Authors:  C Asselin; C Gélinas; P E Branton; M Bastin
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

9.  Correlation between tumor induction and the large external transformation sensitive protein on the cell surface.

Authors:  L B Chen; P H Gallimore; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

10.  Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.

Authors:  R Hirschhorn; N Beratis; F S Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

View more
  33 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.

Authors:  M Yoakim; W Hou; Y Liu; C L Carpenter; R Kapeller; B S Schaffhausen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Transformation by hamster polyomavirus: identification and functional analysis of the early genes.

Authors:  L Goutebroze; J Feunteun
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Failure of simian virus 40 small t antigen to disorganize actin cables in nonpermissive cell lines.

Authors:  B Phillips; K Rundell
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase.

Authors:  J Dahl; R Freund; J Blenis; T L Benjamin
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.

Authors:  K P Mullane; M Ratnofsky; X Culleré; B Schaffhausen
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  Characterization of pp85, a target of oncogenes and growth factor receptors.

Authors:  B Cohen; Y X Liu; B Druker; T M Roberts; B S Schaffhausen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

10.  Polyoma virus small tumor antigen pre-mRNA splicing requires cooperation between two 3' splice sites.

Authors:  H Ge; J Noble; J Colgan; J L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.